Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
30.79
-0.11 (-0.36%)
At close: Mar 9, 2026
35.34% (1Y)
| Market Cap | 14.09B |
| Revenue (ttm) | 1.47B |
| Net Income (ttm) | 74.75M |
| Shares Out | 455.90M |
| EPS (ttm) | 0.17 |
| PE Ratio | 185.23 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,166,832 |
| Average Volume | 11,528,434 |
| Open | 30.75 |
| Previous Close | 30.90 |
| Day's Range | 30.39 - 31.25 |
| 52-Week Range | 18.90 - 31.25 |
| Beta | 0.44 |
| RSI | 74.93 |
| Earnings Date | Apr 25, 2026 |